IL12A — Interleukin-12 Alpha
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">IL12A — Interleukin-12 Alpha</th>
</tr>
<tr>
<td class="label">Cytokine</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">IFN-gamma</td>
<td>Synergistic</td>
</tr>
<tr>
<td class="label">IL-1beta</td>
<td>Additive</td>
</tr>
<tr>
<td class="label">TNF-alpha</td>
<td>Synergistic</td>
</tr>
<tr>
<td class="label">IL-10</td>
<td>Antagonistic</td>
</tr>
<tr>
<td class="label">IL-23</td>
<td>Shared subunit</td>
</tr>
<tr>
<td class="label">Agent</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Ustekinumab</td>
<td>IL-12/23p40</td>
</tr>
<tr>
<td class="label">Briakinumab</td>
<td>IL-12/23p40</td>
</tr>
<tr>
<td class="label">ABBV-951</td>
<td>IL-12</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">34 edges</a></td>
</tr>
</table>
IL12A encodes the p35 subunit (also called IL-12p35) of interleukin-12 (IL-12), a heterodimeric cytokine critical for bridging innate and adaptive immunity. IL-12 is composed of the p35 subunit (encoded by IL12A) and the p40 subunit (encoded by [IL12B](/genes/il12b)), forming the bioactive IL-12p70[@trinchieri2003]. The gene is located on chromosome 3q25.33 and is expressed primarily in dendritic cells, macrophages, B cells, and other antigen-presenting cells["@gately1998"].
Beyond its well-established role in immune regulation, IL-12 has emerged as an important player in neuroinflammation associated with neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS).
Gene Structure and Expression
The IL12A gene spans approximately 20 kb and consists of 7 exons encoding the p35 subunit (253 amino acids). The gene is regulated by multiple promoters and enhancers that control its expression in different immune cell types.
Tissue Distribution
- Immune cells: High expression in dendritic cells, macrophages, monocytes, and B cells
- Central nervous system: Low basal expression in astrocytes and microglia; upregulated in disease states
- Peripheral tissues: Variable expression in spleen, thymus, and lymphoid organs
Regulatory Elements
IL12A expression is regulated by:
- Transcription factors: NF-κB, IRF family members, STAT4
- Epigenetic modifications: DNA methylation and histone acetylation
- Post-transcriptional regulation: miRNAs targeting IL12A mRNA
Protein Structure and Function
IL-12p35 Structure
The p35 subunit belongs to the helical cytokine family and contains:
- N-terminal signal peptide: Directs secretion
- Four-helix bundle core: Cytokine receptor binding domain
- C-terminal extension: Dimerization interface with p40
IL-12 Heterodimer
The functional IL-12 cytokine (IL-12p70) is a heterodimer:
- p35 subunit: Provides the receptor-binding specificity
- p40 subunit: Contains the second receptor-binding site and controls signaling
The IL-12p70 binds to the IL-12 receptor (IL-12Rβ1/IL-12Rβ2) on T cells and NK cells, activating STAT4 and downstream gene expression[@bacon1995].
Biological Functions
Immune Regulation
- Th1 differentiation: IL-12 promotes differentiation of naïve CD4+ T cells into Th1 cells
- IFN-γ production: Stimulates natural killer (NK) cells and T cells to produce interferon-gamma (IFN-γ)
- Cellular immunity: Enhances cytotoxic T lymphocyte (CTL) and NK cell activity
- Anti-tumor immunity: Promotes anti-tumor immune responses
Neuroimmune Functions
In the CNS, IL-12 participates in neuroinflammatory processes:
- Microglial activation: Modulates microglial phenotype and cytokine production
- T cell recruitment: Attracts peripheral T cells to the CNS in neuroinflammation
- Cytokine cascade: Regulates production of other pro-inflammatory cytokines
Role in Neurodegenerative Diseases
Alzheimer's Disease
IL-12 contributes to neuroinflammation in AD through multiple mechanisms:
- Microglial activation: IL-12 enhances microglial production of pro-inflammatory cytokines including IL-1β, TNF-α, and IL-6[@zhou2019]
- Chronic inflammation: Elevated IL-12 levels in AD brain tissue and cerebrospinal fluid correlate with disease severity
- Amyloid-β response: IL-12 may modulate microglial clearance of amyloid-β plaques
- Synaptic dysfunction: Pro-inflammatory cytokines induced by IL-12 can impair synaptic plasticity
Parkinson's Disease
In PD, IL-12 plays a role in dopaminergic neuron loss:
- Neuroinflammation: IL-12 is elevated in the substantia nigra and cerebrospinal fluid of PD patients
- Microglial activation: Chronic IL-12 signaling contributes to persistent microglial activation
- Dopaminergic toxicity: Inflammatory cytokines induced by IL-12 can damage dopaminergic neurons
- α-Synuclein pathology: IL-12 may influence α-synuclein aggregation and spread
Amyotrophic Lateral Sclerosis
IL-12 is implicated in ALS pathogenesis:
- Motor neuron vulnerability: Pro-inflammatory IL-12 signaling may contribute to motor neuron death
- Microgliosis: Enhanced microglial activation in ALS spinal cord
- T cell infiltration: IL-12 may promote inflammatory T cell responses in ALS
Other Neurodegenerative Conditions
- Multiple Sclerosis: IL-12 is a key driver of Th1-mediated demyelination
- Frontotemporal Dementia: Neuroinflammatory IL-12 elevation observed
- Huntington's Disease: Elevated IL-12 in Huntington's disease brain
Therapeutic Implications
IL-12 represents a therapeutic target for neurodegenerative diseases:
IL-12 Blocking Therapies
Ustekinumab and other IL-12/23p40 antibodies (targeting the shared p40 subunit) are approved for psoriasis and IBD and have been explored in:
- Neuroinflammatory disorders: Potential for reducing chronic neuroinflammation
- AD clinical trials: Phase 1/2 trials investigating anti-IL-12/23 in AD
- PD: Investigational approaches targeting IL-12 signaling
Immunomodulation
- Anti-inflammatory compounds: Targeting IL-12 downstream effects
- Microglial modulation: Shifting microglial phenotype from pro-inflammatory to neuroprotective
- T cell regulation: Modulating Th1 responses in the CNS
Challenges
- Complexity: IL-12 has both pro-inflammatory and immunoregulatory roles
- Blood-brain barrier: Therapeutic delivery to the CNS
- Timing: Optimal intervention window in disease progression
Interactions and Signaling Pathways
Cytokine Network
IL-12 interacts with numerous cytokines relevant to neurodegeneration:
Signaling Pathways
- JAK-STAT pathway: IL-12 activates STAT4, STAT3, and STAT5
- NF-κB pathway: Downstream pro-inflammatory gene expression
- PI3K/AKT pathway: Cell survival signaling
- MAPK pathway: Cell proliferation and differentiation
Clinical Significance
Genetic Associations
- IL12A polymorphisms have been associated with susceptibility to autoimmune diseases
- Some variants may influence neurodegenerative disease risk, though evidence is limited
Biomarker Potential
- IL-12 levels in cerebrospinal fluid may serve as neuroinflammatory markers
- IL-12p35 expression in peripheral blood mononuclear cells (PBMCs) correlates with disease activity
Therapeutic Targeting
Research Directions
Key areas of active investigation include:
Mechanism of action: Elucidating IL-12's precise role in neurodegenerative neuroinflammation
Biomarker development: IL-12 as a CSF or blood marker for disease progression
Therapeutic targeting: Developing brain-penetrant IL-12 modulators
Cell-type specificity: Understanding IL-12 effects on neurons vs. glia
Combination therapy: IL-12 modulation with other anti-inflammatory approachesSee Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [NCBI Gene: IL12B](https://www.ncbi.nlm.nih.gov/gene/?term=IL12B)
- [GeneCards: IL12B](https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL12B)
- [OMIM: IL12B](https://omim.org/search?search=IL12B)
- [Ensembl: IL12B](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=IL12B)
- [Allen Brain Atlas: IL12B](https://human.brain-map.org/microarray/search/show?search_term=IL12B)
References
[Trinchieri G, Interleukin-12 and the regulation of innate resistance and adaptive immunity (2003)](https://doi.org/10.1038/nri1001)
[Gately MK, Renzetti LM, Magram J, et al, The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses (1998)](https://doi.org/10.1146/annurev.immunol.16.1.495)
[Bacon CM, McVicar DW, Ortaldo JR, et al, Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of the STAT4 transcription factor for the IL-12 response (1995)](https://doi.org/10.1084/jem.181.1.399)
[Zhou R, Yang G, Guo X, et al, Association of IL-12 and IL-18 polymorphisms with Alzheimer's disease: a meta-analysis (2019)](https://doi.org/10.1007/s00702-019-01991-4)Pathway Diagram
The following diagram shows the key molecular relationships involving IL12A — Interleukin-12 Alpha discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)